Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Format: article
Langue:EN
RU
Publié: Endocrinology Research Centre 2017
Sujets:
Accès en ligne:https://doaj.org/article/d30df532fce74d6d8dfcbb518f2a4ae4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!